In the present study, we therefore focused on a candidate protein–SPDL1, being suspected to underlie genomic (in-)stability in humans, and hypothesized that in CRC, there is a biological interdependence of the SPDL1 expression, clinical outcome, and GIN. The gene discussed is SPDL1; the disease is colorectal carcinoma.